Carl Zeiss Meditec Statistics
Share Statistics
Carl Zeiss Meditec has 87.54M
shares outstanding. The number of shares has increased by -2.08%
in one year.
Shares Outstanding | 87.54M |
Shares Change (YoY) | -2.08% |
Shares Change (QoQ) | 0.05% |
Owned by Institutions (%) | 0% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 100 |
FTD / Avg. Volume | 3.27% |
Short Selling Information
The latest short interest is 125, so 0% of the outstanding
shares have been sold short.
Short Interest | 125 |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 35.3 and the forward
PE ratio is 24.88.
Carl Zeiss Meditec's PEG ratio is
-0.93.
PE Ratio | 35.3 |
Forward PE | 24.88 |
PS Ratio | 3.05 |
Forward PS | 1.8 |
PB Ratio | 3.09 |
P/FCF Ratio | 66.33 |
PEG Ratio | -0.93 |
Financial Ratio History Enterprise Valuation
Carl Zeiss Meditec has an Enterprise Value (EV) of 6.44B.
EV / Sales | 3.12 |
EV / EBITDA | 15.98 |
EV / EBIT | 26.04 |
EV / FCF | 67.71 |
Financial Position
The company has a current ratio of 2.13,
with a Debt / Equity ratio of 0.07.
Current Ratio | 2.13 |
Quick Ratio | 1.19 |
Debt / Equity | 0.07 |
Debt / EBITDA | 0.38 |
Debt / FCF | 1.59 |
Interest Coverage | 6.61 |
Financial Efficiency
Return on Equity is 8.75% and Return on Invested Capital is 5.1%.
Return on Equity | 8.75% |
Return on Assets | 5.27% |
Return on Invested Capital | 5.1% |
Revenue Per Employee | $1,000,061.47 |
Profits Per Employee | $86,508.23 |
Employee Count | 2,066 |
Asset Turnover | 0.61 |
Inventory Turnover | 1.82 |
Taxes
Income Tax | 60.71M |
Effective Tax Rate | 25.21% |
Stock Price Statistics
The stock price has increased by -35.02% in the
last 52 weeks. The beta is 1.24, so Carl Zeiss Meditec's
price volatility has been higher than the market average.
Beta | 1.24 |
52-Week Price Change | -35.02% |
50-Day Moving Average | 66.48 |
200-Day Moving Average | 63.23 |
Relative Strength Index (RSI) | 45.05 |
Average Volume (20 Days) | 3,055 |
Income Statement
In the last 12 months, Carl Zeiss Meditec had revenue of 2.07B
and earned 178.73M
in profits. Earnings per share was 2.01.
Revenue | 2.07B |
Gross Profit | 1.09B |
Operating Income | 194.45M |
Net Income | 178.73M |
EBITDA | 403.06M |
EBIT | 270.29M |
Earnings Per Share (EPS) | 2.01 |
Full Income Statement Balance Sheet
The company has 20.29M in cash and 151.35M in
debt, giving a net cash position of -131.06M.
Cash & Cash Equivalents | 20.29M |
Total Debt | 151.35M |
Net Cash | -131.06M |
Retained Earnings | 1.49B |
Total Assets | 3.39B |
Working Capital | 643.65M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 247.32M
and capital expenditures -152.2M, giving a free cash flow of 95.11M.
Operating Cash Flow | 247.32M |
Capital Expenditures | -152.2M |
Free Cash Flow | 95.11M |
FCF Per Share | 1.07 |
Full Cash Flow Statement Margins
Gross margin is 52.69%, with operating and profit margins of 9.41% and 8.65%.
Gross Margin | 52.69% |
Operating Margin | 9.41% |
Pretax Margin | 11.66% |
Profit Margin | 8.65% |
EBITDA Margin | 19.51% |
EBIT Margin | 9.41% |
FCF Margin | 4.6% |